'en:polydioxanone'
(id=6729087 ; fe=en:polydioxanone ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=1369 creation date=2017-06-21 touchdate=2025-06-12 02:39:48.000) ≈ 46 relations sortantes
- en:polydioxanone --
r_associated #0: 38 / 1 ->
en:biodegradable product
n1=en:polydioxanone | n2=en:biodegradable product | rel=r_associated | relid=0 | w=38
- en:polydioxanone --
r_associated #0: 37 / 0.974 ->
en:polyglycolic acid
n1=en:polydioxanone | n2=en:polyglycolic acid | rel=r_associated | relid=0 | w=37
- en:polydioxanone --
r_associated #0: 35 / 0.921 ->
en:aspects of adverse effects
n1=en:polydioxanone | n2=en:aspects of adverse effects | rel=r_associated | relid=0 | w=35
- en:polydioxanone --
r_associated #0: 35 / 0.921 ->
en:aspects of radiation effects
n1=en:polydioxanone | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=35
- en:polydioxanone --
r_associated #0: 35 / 0.921 ->
en:bone substitutes
n1=en:polydioxanone | n2=en:bone substitutes | rel=r_associated | relid=0 | w=35
- en:polydioxanone --
r_associated #0: 35 / 0.921 ->
en:chemical aspects
n1=en:polydioxanone | n2=en:chemical aspects | rel=r_associated | relid=0 | w=35
- en:polydioxanone --
r_associated #0: 35 / 0.921 ->
en:exposure as collected domain
n1=en:polydioxanone | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=35
- en:polydioxanone --
r_associated #0: 35 / 0.921 ->
en:glycol dimethacrylate
n1=en:polydioxanone | n2=en:glycol dimethacrylate | rel=r_associated | relid=0 | w=35
- en:polydioxanone --
r_associated #0: 35 / 0.921 ->
en:poisoning aspects
n1=en:polydioxanone | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=35
- en:polydioxanone --
r_associated #0: 35 / 0.921 ->
en:polyethylene glycol polymer surgical sealant
n1=en:polydioxanone | n2=en:polyethylene glycol polymer surgical sealant | rel=r_associated | relid=0 | w=35
- en:polydioxanone --
r_associated #0: 34 / 0.895 ->
en:flucrylate
n1=en:polydioxanone | n2=en:flucrylate | rel=r_associated | relid=0 | w=34
- en:polydioxanone --
r_associated #0: 34 / 0.895 ->
en:polyacrylamide hydrogel
n1=en:polydioxanone | n2=en:polyacrylamide hydrogel | rel=r_associated | relid=0 | w=34
- en:polydioxanone --
r_associated #0: 32 / 0.842 ->
en:contraindications aspect
n1=en:polydioxanone | n2=en:contraindications aspect | rel=r_associated | relid=0 | w=32
- en:polydioxanone --
r_associated #0: 32 / 0.842 ->
en:metabolic aspects
n1=en:polydioxanone | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=32
- en:polydioxanone --
r_associated #0: 32 / 0.842 ->
en:pharmacokinetic aspects
n1=en:polydioxanone | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=32
- en:polydioxanone --
r_associated #0: 32 / 0.842 ->
en:polyesters
n1=en:polydioxanone | n2=en:polyesters | rel=r_associated | relid=0 | w=32
- en:polydioxanone --
r_associated #0: 32 / 0.842 ->
en:tricalcium phosphate
n1=en:polydioxanone | n2=en:tricalcium phosphate | rel=r_associated | relid=0 | w=32
- en:polydioxanone --
r_associated #0: 31 / 0.816 ->
en:bioactive glass product
n1=en:polydioxanone | n2=en:bioactive glass product | rel=r_associated | relid=0 | w=31
- en:polydioxanone --
r_associated #0: 31 / 0.816 ->
en:historical aspects qualifier
n1=en:polydioxanone | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=31
- en:polydioxanone --
r_associated #0: 31 / 0.816 ->
en:polyethylene terephthalates
n1=en:polydioxanone | n2=en:polyethylene terephthalates | rel=r_associated | relid=0 | w=31
- en:polydioxanone --
r_associated #0: 30 / 0.789 ->
en:acetylcellulose
n1=en:polydioxanone | n2=en:acetylcellulose | rel=r_associated | relid=0 | w=30
- en:polydioxanone --
r_associated #0: 30 / 0.789 ->
en:dental material
n1=en:polydioxanone | n2=en:dental material | rel=r_associated | relid=0 | w=30
- en:polydioxanone --
r_associated #0: 30 / 0.789 ->
en:polyglactin 910
n1=en:polydioxanone | n2=en:polyglactin 910 | rel=r_associated | relid=0 | w=30
- en:polydioxanone --
r_associated #0: 29 / 0.763 ->
en:absoloks
n1=en:polydioxanone | n2=en:absoloks | rel=r_associated | relid=0 | w=29
- en:polydioxanone --
r_associated #0: 29 / 0.763 ->
en:analysis aspect
n1=en:polydioxanone | n2=en:analysis aspect | rel=r_associated | relid=0 | w=29
- en:polydioxanone --
r_associated #0: 29 / 0.763 ->
en:chemical synthesis
n1=en:polydioxanone | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=29
- en:polydioxanone --
r_associated #0: 29 / 0.763 ->
en:silicone
n1=en:polydioxanone | n2=en:silicone | rel=r_associated | relid=0 | w=29
- en:polydioxanone --
r_associated #0: 29 / 0.763 ->
en:standards characteristics
n1=en:polydioxanone | n2=en:standards characteristics | rel=r_associated | relid=0 | w=29
- en:polydioxanone --
r_associated #0: 28 / 0.737 ->
en:demineralized bone matrix
n1=en:polydioxanone | n2=en:demineralized bone matrix | rel=r_associated | relid=0 | w=28
- en:polydioxanone --
r_associated #0: 28 / 0.737 ->
en:mechanism of action qualifier
n1=en:polydioxanone | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=28
- en:polydioxanone --
r_associated #0: 28 / 0.737 ->
en:polyhydroxyalkanoates
n1=en:polydioxanone | n2=en:polyhydroxyalkanoates | rel=r_associated | relid=0 | w=28
- en:polydioxanone --
r_associated #0: 28 / 0.737 ->
en:toxicity aspects
n1=en:polydioxanone | n2=en:toxicity aspects | rel=r_associated | relid=0 | w=28
- en:polydioxanone --
r_associated #0: 27 / 0.711 ->
en:coated materials, biocompatible
n1=en:polydioxanone | n2=en:coated materials, biocompatible | rel=r_associated | relid=0 | w=27
- en:polydioxanone --
r_associated #0: 27 / 0.711 ->
en:oral facial restoration material
n1=en:polydioxanone | n2=en:oral facial restoration material | rel=r_associated | relid=0 | w=27
- en:polydioxanone --
r_associated #0: 27 / 0.711 ->
en:pds ii (ethicon)
n1=en:polydioxanone | n2=en:pds ii (ethicon) | rel=r_associated | relid=0 | w=27
- en:polydioxanone --
r_associated #0: 27 / 0.711 ->
en:polyethylene glycol hydrogel
n1=en:polydioxanone | n2=en:polyethylene glycol hydrogel | rel=r_associated | relid=0 | w=27
- en:polydioxanone --
r_associated #0: 27 / 0.711 ->
en:tissue marking ink
n1=en:polydioxanone | n2=en:tissue marking ink | rel=r_associated | relid=0 | w=27
- en:polydioxanone --
r_associated #0: 26 / 0.684 ->
en:biomedical material
n1=en:polydioxanone | n2=en:biomedical material | rel=r_associated | relid=0 | w=26
- en:polydioxanone --
r_associated #0: 26 / 0.684 ->
en:fibrin sealant
n1=en:polydioxanone | n2=en:fibrin sealant | rel=r_associated | relid=0 | w=26
- en:polydioxanone --
r_associated #0: 26 / 0.684 ->
en:methyl methacrylate
n1=en:polydioxanone | n2=en:methyl methacrylate | rel=r_associated | relid=0 | w=26
- en:polydioxanone --
r_associated #0: 26 / 0.684 ->
en:plasma substitutes
n1=en:polydioxanone | n2=en:plasma substitutes | rel=r_associated | relid=0 | w=26
- en:polydioxanone --
r_associated #0: 26 / 0.684 ->
en:taxonomic
n1=en:polydioxanone | n2=en:taxonomic | rel=r_associated | relid=0 | w=26
- en:polydioxanone --
r_associated #0: 26 / 0.684 ->
en:tissue scaffolds
n1=en:polydioxanone | n2=en:tissue scaffolds | rel=r_associated | relid=0 | w=26
- en:polydioxanone --
r_associated #0: 21 / 0.553 ->
en:therapeutic use - qualifier
n1=en:polydioxanone | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=21
- en:polydioxanone --
r_associated #0: 20 / 0.526 ->
en:magnesium-based bone void filler
n1=en:polydioxanone | n2=en:magnesium-based bone void filler | rel=r_associated | relid=0 | w=20
- en:polydioxanone --
r_associated #0: 20 / 0.526 ->
polyesters
n1=en:polydioxanone | n2=polyesters | rel=r_associated | relid=0 | w=20
| ≈ 49 relations entrantes
- en:polyesters ---
r_associated #0: 56 -->
en:polydioxanone
n1=en:polyesters | n2=en:polydioxanone | rel=r_associated | relid=0 | w=56
- polyesters ---
r_associated #0: 54 -->
en:polydioxanone
n1=polyesters | n2=en:polydioxanone | rel=r_associated | relid=0 | w=54
- en:fibrin sealant ---
r_associated #0: 35 -->
en:polydioxanone
n1=en:fibrin sealant | n2=en:polydioxanone | rel=r_associated | relid=0 | w=35
- en:absoloks ---
r_associated #0: 34 -->
en:polydioxanone
n1=en:absoloks | n2=en:polydioxanone | rel=r_associated | relid=0 | w=34
- en:biomedical material ---
r_associated #0: 34 -->
en:polydioxanone
n1=en:biomedical material | n2=en:polydioxanone | rel=r_associated | relid=0 | w=34
- en:bone substitutes ---
r_associated #0: 34 -->
en:polydioxanone
n1=en:bone substitutes | n2=en:polydioxanone | rel=r_associated | relid=0 | w=34
- en:coated materials, biocompatible ---
r_associated #0: 34 -->
en:polydioxanone
n1=en:coated materials, biocompatible | n2=en:polydioxanone | rel=r_associated | relid=0 | w=34
- en:magnesium-based bone void filler ---
r_associated #0: 34 -->
en:polydioxanone
n1=en:magnesium-based bone void filler | n2=en:polydioxanone | rel=r_associated | relid=0 | w=34
- en:pds ii (ethicon) ---
r_associated #0: 34 -->
en:polydioxanone
n1=en:pds ii (ethicon) | n2=en:polydioxanone | rel=r_associated | relid=0 | w=34
- en:biodegradable product ---
r_associated #0: 32 -->
en:polydioxanone
n1=en:biodegradable product | n2=en:polydioxanone | rel=r_associated | relid=0 | w=32
- en:flucrylate ---
r_associated #0: 32 -->
en:polydioxanone
n1=en:flucrylate | n2=en:polydioxanone | rel=r_associated | relid=0 | w=32
- en:polyglactin 910 ---
r_associated #0: 32 -->
en:polydioxanone
n1=en:polyglactin 910 | n2=en:polydioxanone | rel=r_associated | relid=0 | w=32
- en:therapeutic use - qualifier ---
r_associated #0: 32 -->
en:polydioxanone
n1=en:therapeutic use - qualifier | n2=en:polydioxanone | rel=r_associated | relid=0 | w=32
- en:mechanism of action qualifier ---
r_associated #0: 31 -->
en:polydioxanone
n1=en:mechanism of action qualifier | n2=en:polydioxanone | rel=r_associated | relid=0 | w=31
- en:exposure as collected domain ---
r_associated #0: 30 -->
en:polydioxanone
n1=en:exposure as collected domain | n2=en:polydioxanone | rel=r_associated | relid=0 | w=30
- en:methyl methacrylate ---
r_associated #0: 30 -->
en:polydioxanone
n1=en:methyl methacrylate | n2=en:polydioxanone | rel=r_associated | relid=0 | w=30
- en:oral facial restoration material ---
r_associated #0: 30 -->
en:polydioxanone
n1=en:oral facial restoration material | n2=en:polydioxanone | rel=r_associated | relid=0 | w=30
- en:plasma substitutes ---
r_associated #0: 30 -->
en:polydioxanone
n1=en:plasma substitutes | n2=en:polydioxanone | rel=r_associated | relid=0 | w=30
- en:silicone ---
r_associated #0: 30 -->
en:polydioxanone
n1=en:silicone | n2=en:polydioxanone | rel=r_associated | relid=0 | w=30
- en:bioactive glass product ---
r_associated #0: 29 -->
en:polydioxanone
n1=en:bioactive glass product | n2=en:polydioxanone | rel=r_associated | relid=0 | w=29
- en:polyethylene glycol hydrogel ---
r_associated #0: 29 -->
en:polydioxanone
n1=en:polyethylene glycol hydrogel | n2=en:polydioxanone | rel=r_associated | relid=0 | w=29
- en:polyethylene terephthalates ---
r_associated #0: 29 -->
en:polydioxanone
n1=en:polyethylene terephthalates | n2=en:polydioxanone | rel=r_associated | relid=0 | w=29
- en:tissue marking ink ---
r_associated #0: 29 -->
en:polydioxanone
n1=en:tissue marking ink | n2=en:polydioxanone | rel=r_associated | relid=0 | w=29
- en:polyethylene glycol polymer surgical sealant ---
r_associated #0: 28 -->
en:polydioxanone
n1=en:polyethylene glycol polymer surgical sealant | n2=en:polydioxanone | rel=r_associated | relid=0 | w=28
- en:polyglycolic acid ---
r_associated #0: 28 -->
en:polydioxanone
n1=en:polyglycolic acid | n2=en:polydioxanone | rel=r_associated | relid=0 | w=28
- en:polyhydroxyalkanoates ---
r_associated #0: 28 -->
en:polydioxanone
n1=en:polyhydroxyalkanoates | n2=en:polydioxanone | rel=r_associated | relid=0 | w=28
- en:standards characteristics ---
r_associated #0: 28 -->
en:polydioxanone
n1=en:standards characteristics | n2=en:polydioxanone | rel=r_associated | relid=0 | w=28
- en:tissue scaffolds ---
r_associated #0: 28 -->
en:polydioxanone
n1=en:tissue scaffolds | n2=en:polydioxanone | rel=r_associated | relid=0 | w=28
- en:toxicity aspects ---
r_associated #0: 28 -->
en:polydioxanone
n1=en:toxicity aspects | n2=en:polydioxanone | rel=r_associated | relid=0 | w=28
- en:tricalcium phosphate ---
r_associated #0: 28 -->
en:polydioxanone
n1=en:tricalcium phosphate | n2=en:polydioxanone | rel=r_associated | relid=0 | w=28
- en:historical aspects qualifier ---
r_associated #0: 26 -->
en:polydioxanone
n1=en:historical aspects qualifier | n2=en:polydioxanone | rel=r_associated | relid=0 | w=26
- en:pharmacokinetic aspects ---
r_associated #0: 26 -->
en:polydioxanone
n1=en:pharmacokinetic aspects | n2=en:polydioxanone | rel=r_associated | relid=0 | w=26
- en:polyacrylamide hydrogel ---
r_associated #0: 25 -->
en:polydioxanone
n1=en:polyacrylamide hydrogel | n2=en:polydioxanone | rel=r_associated | relid=0 | w=25
- en:aspects of radiation effects ---
r_associated #0: 24 -->
en:polydioxanone
n1=en:aspects of radiation effects | n2=en:polydioxanone | rel=r_associated | relid=0 | w=24
- en:chemical synthesis ---
r_associated #0: 24 -->
en:polydioxanone
n1=en:chemical synthesis | n2=en:polydioxanone | rel=r_associated | relid=0 | w=24
- en:contraindications aspect ---
r_associated #0: 24 -->
en:polydioxanone
n1=en:contraindications aspect | n2=en:polydioxanone | rel=r_associated | relid=0 | w=24
- en:analysis aspect ---
r_associated #0: 23 -->
en:polydioxanone
n1=en:analysis aspect | n2=en:polydioxanone | rel=r_associated | relid=0 | w=23
- en:chemical aspects ---
r_associated #0: 23 -->
en:polydioxanone
n1=en:chemical aspects | n2=en:polydioxanone | rel=r_associated | relid=0 | w=23
- en:demineralized bone matrix ---
r_associated #0: 23 -->
en:polydioxanone
n1=en:demineralized bone matrix | n2=en:polydioxanone | rel=r_associated | relid=0 | w=23
- en:metabolic aspects ---
r_associated #0: 23 -->
en:polydioxanone
n1=en:metabolic aspects | n2=en:polydioxanone | rel=r_associated | relid=0 | w=23
- en:glycol dimethacrylate ---
r_associated #0: 22 -->
en:polydioxanone
n1=en:glycol dimethacrylate | n2=en:polydioxanone | rel=r_associated | relid=0 | w=22
- en:taxonomic ---
r_associated #0: 22 -->
en:polydioxanone
n1=en:taxonomic | n2=en:polydioxanone | rel=r_associated | relid=0 | w=22
- en:acetylcellulose ---
r_associated #0: 21 -->
en:polydioxanone
n1=en:acetylcellulose | n2=en:polydioxanone | rel=r_associated | relid=0 | w=21
- en:aspects of adverse effects ---
r_associated #0: 21 -->
en:polydioxanone
n1=en:aspects of adverse effects | n2=en:polydioxanone | rel=r_associated | relid=0 | w=21
- en:dental material ---
r_associated #0: 21 -->
en:polydioxanone
n1=en:dental material | n2=en:polydioxanone | rel=r_associated | relid=0 | w=21
- en:poisoning aspects ---
r_associated #0: 21 -->
en:polydioxanone
n1=en:poisoning aspects | n2=en:polydioxanone | rel=r_associated | relid=0 | w=21
- matériau dentaire ---
r_associated #0: 10 -->
en:polydioxanone
n1=matériau dentaire | n2=en:polydioxanone | rel=r_associated | relid=0 | w=10
- méthacrylate de méthyle ---
r_associated #0: 10 -->
en:polydioxanone
n1=méthacrylate de méthyle | n2=en:polydioxanone | rel=r_associated | relid=0 | w=10
- taxinomique ---
r_associated #0: 10 -->
en:polydioxanone
n1=taxinomique | n2=en:polydioxanone | rel=r_associated | relid=0 | w=10
|